As the Market’s overheating, (Nasdaq: LABD) the S&P Biotech Bear 3x hits all-time lows, and Brexit fears loom. LABD gives a nice potential entry for biotech traders looking for protection the next couple weeks to hedge their portfolios. LABD moves sharply up and down like the VIX when market is in overbought conditions. Keep in mind, just because I am hedging my portfolio with LABD I still believe there are select biotechs that will do great.
LABD aligning with political concerns & dates that could potentially shake the market.
Technical setup for LABD:
Chart indicating Bullish Harmonic ratio, bouncing off 113 retracement (also referred to as the “bullish” 113) is a sign of potential reversal for the S&P Biotech Bear 3x (blue line). Brexit meeting is coming up in a few days, giving good case for a pullback in the S&P 500, Dow, Nasdaq, and related ETF’s; especially biotech as most are heavy with debt. Biotech ETF’s have been up ~25-30% ytd because of optimism in M&A activity. Even if Brexit is a nothing burger for the market, it is my opinion that we are due for a pullback as broader markets seem to be peaking and overbought signals haunt.
As long as the S&P and other ETF’s hold higher lows on a hypothetical pullback this will be known as a bullish correction. With LABD being cheap at the moment it is a great way to hedge risk in times of volatility for the MS team.
My plan is to watch the horizontal green lines, which I see as short-term resistance. I am looking for LABD to run into the $18-21 range then re-assessing whether or not to take profits into Brexit results.
This is my opinion, please do your homework before investing. I will be posting updates in the MS Forum.
I am/ we are long LABD.
MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates are not registered financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.
The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.